Vaccine Market 2019 Size, Share, Analysis by Influenza, DTP, Pneumococcal Disease, Human Papilloma Virus, Polio, Rotavirus, Hepatitis, Varicella, Dengue, & others) Industry Set to Rise at 7% CAGR by 2025

Global Vaccine Market 219-2025: The global Vaccine Marketwas valued at USD 32.1 billion in 2016 and is anticipated to touch a value of US$ 59.01 billion by 2025, growing at a CAGR of 7% from 2017 to 2025.

Things Covered in Sample Report
> Deep Dive Strategy & Competition
> Deep Dive Data & Forecasting
> Executive Summary & Core Findings

Get a Quick Sample report at https://decisionmarketreports.com/request-sample?productID=950986&utm_source=sd

Competitive Landscape:
The major players in the market are as follows:
1. Pfizer, Inc.
2. Glaxosmithkline PLC.
3. Merck & Co., Inc.
4. Sanofi Pasteur SA
5. CSL Limited
6. Emergent Biosolutions, Inc.
7. Johnson & Johnson
8. Medimmune, LLC (A Subsidiary of Astrazeneca)
9. AstellasPharma, Inc.
10. Serum Institute of India
11. Bavarian Nordic
12. Mitsubishi Tanabe Pharma Corporation
13. Daiichi Sankyo Company, Limited
14. Protein Sciences Corporation
15. Panacea Biotec

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/950986/global-vaccine-market?utm_source=sd

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism. The vaccine production market is seeing a rise because of prevalence of infections and flu diseases.

Market Dynamics:
1. Market Drivers
1.1 Increasing Cases of infections
1.2 Growing demand of immunization campaigns and programs
1.3 Growing focus on vaccine development and implementation
1.4 More funds for vaccine R&D in industries
2. Market Restraints
2.1 Product failure
2.2 High Cost of Vaccine development

Market Segmentation:
1. Global Vaccine Market, by Type:
1.1 Monovalent
1.2 Multivalent

2. Global Vaccine Market, by Technology:
2.1 Conjugate Vaccines
2.2 Inactivated and Subunit Vaccines
2.3 Live Attenuated Vaccines
2.4 Recombinant Vaccines
2.5 Toxoid Vaccines

3. Global Vaccine Market, by path ofAdministration:
3.1 Intramuscular and Subcutaneous Administration
3.2 Oral Administration
3.3 Other Routes of Administration

4. Global Vaccine Market, by Disease Indication:
4.1 Pneumococcal Disease
4.2 DTP
4.3 Influenza
4.4 Human Papilloma Virus
4.5 Meningococcal Disease
4.6 Polio
4.7 Rotavirus
4.8 Hepatitis
4.9 MMR
4.10 Varicella
4.11 Dengue
4.12 Other Disease Indications

5. Global Vaccine Market, by path ofEnd user:
5.1 Pediatrics
5.2 Adults
5.3 Veterinary Practices (Animals)

6. Global Vaccine Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

To Know more about Methodology of this report @ https://decisionmarketreports.com/request-methodolgy?productID=950986&utm_source=sd

Table of Content

1 INTRODUCTION OF GLOBAL VACCINE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL VACCINE MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL VACCINE MARKET, BY TYPE
5.1 Overview
5.2 Monovalent
5.3 Multivalent

6 GLOBAL VACCINE MARKET, BY TECHNOLOGY
6.1 Overview
6.2 Conjugate Vaccines
6.3 Inactivated and Subunit Vaccines
6.4 Live Attenuated Vaccines
6.5 Recombinant Vaccines
6.6 Toxoid Vaccines

7 GLOBAL VACCINE MARKET, BY PATH OF ADMINISTRATION
7.1 Overview
7.2 Intramuscular and Subcutaneous Administration
7.3 Oral Administration
7.4 Others

8 GLOBAL VACCINE MARKET, BY DISEASE INDICATION
8.1 Overview
8.2 Pneumococcal Disease
8.3 DTP
8.4 Influenza
8.5 Human Papilloma Virus
8.6 Meningococcal Disease
8.7 Polio
8.8 Rotavirus
8.9 Hepatitis
8.10 MMR
8.11 Varicella
8.12 Dengue
8.13 Others

9 GLOBAL VACCINE MARKET, BY PATH OF END USER
9.1 Overview
9.2 Pediatrics
9.3 Adults
9.4 Veterinary Practices (Animals)

10 GLOBAL VACCINE MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 – 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 – 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 – 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 – 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025

11 GLOBAL VACCINE MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Pfizer, Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Glaxosmithkline PLC.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Merck & Co., Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Sanofi Pasteur SA
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 CSL Limited
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Emergent Biosolutions, Inc.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 Johnson & Johnson
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Medimmune, LLC
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 AstellasPharma, Inc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 Bavarian Nordic
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Mitsubishi Tanabe Pharma Corporation
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Daiichi Sankyo Company, Limited
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Protein Sciences Corporation
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

12.14 Panacea Biotec
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments

12.15 Serum Institute of India
12.15.1 Overview
12.15.2 Financial Performance
12.15.3 Product Outlook
12.15.4 Key Developments

13 Appendix
13.1 Related Reports

Request a In-depth Insights PDF Sample Brochure @ https://decisionmarketreports.com/request-sample?productID=950986&utm_source=sd

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com

This release was published on openPR.